ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,81%
Bitcoin
67.495,12
-1,27%
Brent Oil
81,295
-0,80%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Glycogenesys Inc. (MM) (GLGS)

  7. Glycogenesys Inc. (MM) (GLGS) Notícias

GLGS

Glycogenesys (GLGS)

Glycogenesys Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GLGS
DataHoraFonteTítuloCódigoCompanhia
03/02/200611:00PR Newswire (US)GlycoGenesys, Inc. Announces Chapter 11 Filing, Reduction in Work Force and Senior Management ChangesNASDAQ:GLGSGlycogenesys Inc. (MM)
04/01/200617:00Business WireGlycoGenesys, Inc. Requests Hearing to Appeal Nasdaq Staff DeterminationNASDAQ:GLGSGlycogenesys Inc. (MM)
23/11/200519:58Business WireGlycoGenesys, Inc. Comments on 2005 Third Quarter Financial Results and Stock Listing Status; Quarterly Conference Call ScheduleNASDAQ:GLGSGlycogenesys Inc. (MM)
17/11/200512:10Business WireGlycoGenesys Initiates Additional Prestigious Medical Site for GCS-100 Phase I/II Multiple Myeloma Clinical Trial; Patient ScreeNASDAQ:GLGSGlycogenesys Inc. (MM)
04/11/200512:45Business WireGlycoGenesys to Present at the Bio-Europe 2005 Partnering ConferenceNASDAQ:GLGSGlycogenesys Inc. (MM)
04/11/200512:25Business WireGlycoGenesys to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceNASDAQ:GLGSGlycogenesys Inc. (MM)
24/10/200511:20Business WireGlycoGenesys, Inc. Announces $20.0 Million Common Stock Purchase Agreement with Fusion CapitalNASDAQ:GLGSGlycogenesys Inc. (MM)
27/09/200516:20PR Newswire (US)ChineseWorldNet.com Inc. to Host Global Chinese Financial Forum in TorontoNASDAQ:GLGSGlycogenesys Inc. (MM)
19/09/200510:25Business WireNew Preclinical Discovery Shows GlycoGenesys' Cancer Drug Candidate GCS-100 Inhibits AKT1 (Promoter of Cancer Cell Survival andNASDAQ:GLGSGlycogenesys Inc. (MM)
16/09/200515:57Business WireNew Mechanistic Frame Work For GlycoGenesys' Cancer Drug Candidate GCS-100 Published in The Journal Cancer ResearchNASDAQ:GLGSGlycogenesys Inc. (MM)
09/09/200511:00PR Newswire (US)Scimitar Equity Research Issues Review of GlycoGenesys, Inc.NASDAQ:GLGSGlycogenesys Inc. (MM)
08/09/200510:30Business WireGlycoGenesys, Inc. Achieves Primary Objective in Phase I Trial in Advanced Solid Tumors Preliminary Response Data on 14 PatientsNASDAQ:GLGSGlycogenesys Inc. (MM)
30/08/200516:00Business WireGlycoGenesys, Inc. to Announce Clinical Data and Present at Roth Capital Partners New York Conference September 8th, 2005NASDAQ:GLGSGlycogenesys Inc. (MM)
19/08/200510:15Business WireGlycoGenesys, Inc. Comments on 2005 Second Quarter Financial ResultsNASDAQ:GLGSGlycogenesys Inc. (MM)
16/08/200509:00Business WireGlycoGenesys, Inc. Conference Call Alert For August 22, 2005NASDAQ:GLGSGlycogenesys Inc. (MM)
08/08/200510:17Business WireGlycoGenesys, Inc. Provides Update on Corporate and Clinical Plans Going ForwardNASDAQ:GLGSGlycogenesys Inc. (MM)
05/07/200511:45Business WireGlycoGenesys, Inc. Achieves Compliance with Nasdaq Listing RequirementNASDAQ:GLGSGlycogenesys Inc. (MM)
15/06/200510:12Business WireNew Discovery Provides Mechanistic Picture of How GlycoGenesys' GCS-100 Targets Malignant Lymphoma Cells And Induces Cell DeathNASDAQ:GLGSGlycogenesys Inc. (MM)
07/06/200511:31Business WireGlycoGenesys, Inc.'s GCS-100 Subject of Talk By Dr. Finbarr Cotter At The 9th International Conference On Malignant Lymphoma inNASDAQ:GLGSGlycogenesys Inc. (MM)
01/06/200510:22Business WireU.S. Patent Office Grants Patent for Use of GlycoGenesys, Inc.'s GCS-100 to Treat Angiogenesis-Related DiseasesNASDAQ:GLGSGlycogenesys Inc. (MM)
10/05/200515:16Business WireGlycoGenesys, Inc. Shareholders Approve Private Placement Proposal at Special MeetingNASDAQ:GLGSGlycogenesys Inc. (MM)
02/05/200510:00Business WireGlycoGenesys to Present at the Second Annual Rodman & Renshaw Techvest Global Healthcare ConferenceNASDAQ:GLGSGlycogenesys Inc. (MM)
01/03/200418:39PR Newswire (US)Webcast Alert: GlycoGenesys, Inc. (GLGS) Presentation At RedChip Resources and Moors & Cabot's Small-Cap Investor ConferenceNASDAQ:GLGS
 Apresentando as notícias mais relevantes sobre:NASDAQ:GLGS

Seu Histórico Recente

COIN
FDCUST
FintraDAO Coin
BIT
P1XLH5
NLBNPIT1XLH5 20240621 1900
ASX
MVB
VanEck Investments
BIT
P20RL2
NLBNPIT20RL2 20991231 12...
BIT
P1YAR5
NLBNPIT1YAR5 20991231 3....
BIT
UI363C
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados